Home » Push Toward Personalized Drug Development Faces Obstacles
Push Toward Personalized Drug Development Faces Obstacles
April 14, 2006
The FDA and the pharma industry face numerous obstacles to implementing a personalized approach to developing new medicines. For the agency, the problems include privacy concerns, financial limits and regulatory roadblocks, says HHS Secretary Mike Leavitt.